Kaygisiz, Kübra http://orcid.org/0000-0003-0077-7867
Rauch-Wirth, Lena http://orcid.org/0000-0002-0952-3559
Dutta, Arghya http://orcid.org/0000-0003-2116-6475
Yu, Xiaoqing
Nagata, Yuki http://orcid.org/0000-0001-9727-6641
Bereau, Tristan
Münch, Jan http://orcid.org/0000-0001-7316-7141
Synatschke, Christopher V. http://orcid.org/0000-0002-4259-6696
Weil, Tanja http://orcid.org/0000-0002-5906-7205
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (16249678—SFB 1279, Emmy Noether program)
Article History
Received: 27 February 2023
Accepted: 1 August 2023
First Online: 23 August 2023
Competing interests
: J.M. and L.R.W. hold patents and K.K., L.R.W., C.V.S., J.M. and T.W. submitted a patent for application of peptide fibrils for retroviral transduction enhancement. The remaining authors declare no competing interests. The authors have no relevant non-financial interests to disclose.